Department of Orthopedics, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
J Arthroplasty. 2012 May;27(5):679-86. doi: 10.1016/j.arth.2011.08.008. Epub 2011 Oct 13.
Fifty-one osteonecrotic hips in 40 patients were randomly divided into 2 treatment groups. Patients in group A (25 hips) were treated with core decompression, and those in group B (26 hips) received autologous bone marrow mononuclear cell instillation into the core tract after core decompression. Outcome between the 2 groups were compared clinically (Harris Hip score), radiographically (x-ray and magnetic resonance imaging), and by Kaplan-Meier hip survival analysis after 12 and 24 months of surgical intervention. The clinical score and mean hip survival were significantly better in group B than in group A (P < .05). Patients with adverse prognostic features at initial presentation, that is, poor Harris Hip score, x-ray changes, edema, and/or effusion on magnetic resonance imaging had significantly better clinical outcome and hip survival in group B than in group A.
40 名患者的 51 个股骨头坏死髋部被随机分为 2 个治疗组。A 组(25 髋)患者接受核心减压治疗,B 组(26 髋)患者在核心减压后将自体骨髓单核细胞注入核心管。比较两组的临床(Harris 髋关节评分)、影像学(X 线和磁共振成像)和 Kaplan-Meier 髋关节生存分析结果,术后 12 个月和 24 个月。B 组的临床评分和平均髋关节生存率明显优于 A 组(P <.05)。在初始表现时有不良预后特征的患者,即 Harris 髋关节评分低、X 线改变、水肿和/或磁共振成像上的积液,在 B 组的临床结果和髋关节生存率明显优于 A 组。